PEDIATRICS Vol. 99 No. 3 March 1997,
p. e6
Copyright ©1997 by the American Academy of Pediatrics
ELECTRONIC ARTICLE:
Admixture of a Multivitamin Preparation to Parenteral
Nutrition: The Major Contributor to In Vitro Generation of
Peroxides
Jean-Claude Lavoie*,
Sylvie Bélanger
,
Monica Spalinger, and
Pharm*; and Philippe Chessex*,
From the * Research Center of Hospital Sainte-Justine and the
Department of Pediatrics, University of Montreal, Montreal, Quebec,
Canada.
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
ABBREVIATIONS
REFERENCES
ABSTRACT
Background. Peroxides have been
reported to contaminate lipid emulsions and amino acid solutions used
in total parenteral nutrition (TPN). This is particularly disturbing in
newborn infants who are prone to several diseases related to immature
defense mechanisms against oxidative challenges. It is not clear
whether the antioxidants in multivitamins help protect parenteral
nutrients against the hazards of oxidation.
Objective. To evaluate the role of a multivitamin
preparation (MVI) on the actual peroxide load received by patients on
TPN.
Methodology. The generation of peroxides in parenteral
nutrition was tested first using test solutions. We compared the
relative contribution of commercially available amino acid solutions, a lipid emulsion, and MVI on the level of peroxides in clinically relevant TPN solutions. Second, we measured the level of peroxides actually infused at the bedside. In both circumstances, the effects of
time and light exposure were isolated. The level of peroxides was
determined by a colorimetric technique and expressed as
µM equivalents tert-butyl hydroperoxide
(µM = TBH).
Results. Even when protected from light, the addition of
MVI produced a 10-fold increase in peroxides (mean ± SEM, n = 3, 19 ± 4 to 189 ± 8 µM = TBH at 4 h)
in the fat-free TPN solution and a fourfold increase (64 ± 6 to
244 ± 8 µM = TBH at 4 h) in the
lipid-containing TPN solution. A dose-response relationship was found
between the concentration of MVI and peroxide levels. The effect of
light was the strongest in the presence of multivitamins. The amino
acid solutions had a relative inhibitory effect on the generation of
peroxides by MVI, which varied (from 54 ± 1% to 72 ± 1%)
all according to the amino acid blend. In parenterally fed premature
infants, protecting the intravenous set from light decreased the load
of infused peroxides (146 ± 15 vs 215 ± 24 µM = TBH).
Conclusions. The lipid emulsion had a significant but
minor additive effect compared with the multivitamin preparation, which was the major contributor to the generation of peroxides. Protection from photooxidation is not sufficient to prevent peroxidation of TPN
solutions. Contrary to what one would expect, increasing the
concentration of MVI will lead to a greater generation of peroxides,
suggesting that the essential antioxidants in MVI do not have
antiperoxide properties. amino acids, antioxidants,
detergents, lipids, newborn infants, oxidation, parenteral nutrition.
INTRODUCTION
Isolated constituents of total parenteral nutrition (TPN)
represent a potential source of oxidants. Because lipids infused with
TPN solutions are contaminated by peroxides,1,2 these emulsions are often believed to be the major source of oxidants in
solutions of parenteral alimentation. However, other nutrients can
promote peroxidation such as amino acids,3,4
vitamins,5,6 trace metals,7 and additives used
for stability.8 But the total peroxide load received by
patients on TPN has not been clearly established.
Peroxides are products of oxidation, but they can also become highly
reactive oxygen species in the presence of trace metals. Increasing
evidence indicates that these sources of oxidants disrupt cell membrane
integrity and mediate tissue injury.9 Furthermore, the
oxidation can cause changes in the quality of solutions,12 as well as loss of potency of parenteral nutrients, because the concentrations of several vitamins and amino acids decrease in TPN
solutions exposed to light.12 In the face of immature
antioxidant defenses, infused peroxides have the potential to cause an
oxidative challenge with general effects or local repercussions at the
site of infusion. This is supported by the demonstration that the
infusion of an antiperoxide such as bisulfite was associated in
parenterally fed infants with a drop in urinary
malondialdehyde,8 a marker of peroxidation13.
At the site of infusion, tert-butyl hydroperoxide (TBH) induced an
oxidative response in endothelial cells characterized by modifications
in prostaglandin and glutathione productions.14
Multivitamin preparations contain several antioxidants such as
ascorbate, tocopherol, vitamin A, mannitol, butylhydroxytoluene. Therefore, one would expect the multivitamins to help protect parenteral nutrients against the hazards of oxidation. This is supported by the observation that ascorbate hinders the generation of
peroxides in a lipid emulsion.15 These antioxidants act as chain-breaking agents by scavenging peroxyl radicals and reactive oxygen species. Multivitamin preparations also contain molecules associated with the generation of peroxides, such as
riboflavin16 and detergents.17 It is not clear
whether multivitamins have antiperoxide properties.
The aim of our study was to evaluate the role of a multivitamin
preparation on the actual peroxide load received by patients on TPN.
METHODS
The peroxide-generating capacity of parenteral nutrition was
tested first on the bench by comparing the relative contribution of
amino acids, lipids, and the multivitamin preparation, as well as by
comparing different commercially available amino acid preparations. Second, it was also tested at the bedside.
Test Solutions
The generation of peroxides was compared between different TPN
preparations left at darkness or at daylight for 6 h. The tested solutions contained clinically relevant concentrations of individual parenteral nutrients delivered to newborn infants:
(a) fat-free and vitamin-free parenteral
nutrition (PN) = 2.5% (w/v) amino acids (Travasol 10% Blend C;
Clintec Canada, Mississauga, Ontario, Canada) plus 10% (w/v) dextrose
plus standard electrolytes and trace elements (Micro + 6 Pediatric, Sabex International, Montreal, Quebec, Canada);
(b) PN + LIPIDS = the same as in
a, to which the lipid emulsion Intralipid-10% (Pharmacia
Inc, Mississauga, Ontario, Canada) was added to obtain a final 5.5%
(v/v) concentration; (c) PN + multivitamin preparation (MVI) = the same as in a, to which
the multivitamin preparation MVI Pediatric (Rhône Poulenc Rorer,
Montreal, Quebec, Canada) was added to obtain a final 1% (v/v)
concentration; (d) PN + LIPIDS + MVI = the same as in b, to which the multivitamin
preparation MVI Pediatric was added to obtain a final 1% (v/v)
concentration. All these solutions were prepared in water to obtain a
constant concentration of nutrients. Furthermore, a dose-response
relationship was sought between MVI in water and peroxides after 3 h of exposure to daylight.
As bags of TPN are changed daily, the effect of a 24-h exposure to
daylight was sought in the following preparations, characterized by
varying amino acid contents in the face of a constant MVI concentration (1%) relative to the final volume: 100% PN; 50% PN + 49%
H2O + 1% MVI; 25% PN + 74%
H2O + 1% MVI; 15% PN + 84%
H2O + 1% MVI; 99% H20 + 1% MVI.
Commercially available 10% (w/v) amino acid solutions provided us with
the opportunity to isolate the effects of amino acid blends as well as
bisulfite and cysteine hydrochloride, both known for their antioxidant
properties8,18 on peroxide generation. The level of
peroxidation was compared after 18 h of light exposure under the
same experimental conditions as described above for the 25% PN + 74% H2O + 1% MVI preparation. The following amino acid solutions were analyzed. Blend C: Travasol 10% Blend C in glass,
(Clintec Canada), which contains 300 mg/L bisulfite, but no cysteine;
TIV: Travasol 10% Blend C in Viaflex, (Clintec Canada), which has the
same amino acid blend but contains no bisulfite and no cysteine;
Primene: Primene 10% (Clintec Canada), which has a different amino
acid blend and no bisulfite, but 2460 mg/L cysteine hydrochloride;
Aminosyn: Aminosyn PF (Abbott Laboratories, Montreal, Quebec, Canada)
contains <300 mg/L bisulfite to which cysteine hydrochloride was added
at either 0 mg/L or 500 mg/L as the maximum recommended by the
manufacturer; Trophamine: Trophamine 10% (McGaw Inc, Irvine,
California) contains <500 mg/L bisulfite and <240 mg/L cysteine
hydrochloride.
At the Bedside
To verify that the findings in the test solutions were of
relevance to patient care, we sought to confirm the presence of peroxides in TPN solutions actually delivered to preterm infants. The
effect of protecting the parenteral solution from photooxidation during
the transit from the bag to the patient was tested on the peroxide
content. The concentrations of amino acid (Blend C) and dextrose were
ordered by the attending physician; all solutions were supplemented
with standard electrolytes, trace elements (Micro + Pediatric),
and 2.5 mL/d multivitamin preparation (MVI Pediatric). According to
routine procedures, all bags containing TPN solutions hang at the
bedside, protected from light by an opaque plastic cover that is open
toward the bottom. Twenty-two hours after infusing fat-free TPN
preparations, a sample was taken simultaneously from the bag and from
the extension set (Baxter, Toronto, Ontario, Canada) at the closest
sampling site to the infant. This procedure was performed in two groups
of infants: (1) those fitted with the
unprotected extension set according to routine procedures, and
(2) those with the same tubing but protected
from light with a custom-made opaque plastic sleeve extending from the
TPN bag to the infusion pump and from that device to the patient. To
ensure similar transit time and experimental conditions in both groups, patients were selected so that the infusion rates were comparable (between 4 and 7 mL/h) and MVI concentrations within a range of 1% to
2.5% (v/v) of final solution.
To quantify hydroperoxides in the TPN solutions, the ferrous
oxidation/xylenol orange technique was used as described
previously.19 All reagents were purchased from Aldrich
Chemical Company (Milwaukee, Wisconsin). At low pH, Fe2+ is
oxidized in the presence of hydroperoxides; the formed Fe3+
reacts with xylenol orange to produce a chromophore that absorbs at 560 nm linearly with the concentration of a wide range of
hydroperoxides.8 In the present study, 22.5 mM
H2SO4, 90 µM xylenol orange, 225 µM FeCl2, and 3.6 mM BHT were
added to 100 µL of sample, for a total volume of 1 mL. The absorbance
was read (Beckman spectrophotometer DU-6) after 30 min incubation at
room temperature. Intra- and interassay coefficients of variation were
4% and 5%, respectively. Hydroperoxides were expressed in
µM equivalents of TBH (µM = TBH). The level
of detection within a 95% confidence limit was 2.7 µM = TBH. To confirm that the solutions did generate peroxides, they were
also tested after exposure to the following antiperoxides: 50 U/mL
catalase (Sigma Chemical Co, St Louis, Missouri) or 1 mM
bisulfite (Fisher Scientific Ltd, Montreal, Quebec, Canada).
Statistics
The data are presented as the mean ± SEM. Unless otherwise
stated, measurements were performed in triplicate. The effects of
nutrients, daylight, and duration of exposure were isolated in a 4 × 2 × 2 × 2 (time × LIPID × MVI × light)
multifactorial ANOVA. The effect of bisulfite was isolated by comparing
Blend C vs TIV. The effects of cysteine and amino acid blends were
isolated in a 2 × 2 × 2 multifactorial ANOVA (Blend C ± 500 mg/L cysteine hydrochloride vs Aminosyn ± 500 mg/L
cysteine hydrochloride). At the bedside, the effect of daylight on
peroxidation was isolated by ANOVA. The level of significance was set
at P <.05.
RESULTS
Hydroperoxides were detected in newly open bottles of
Intralipid-10% (134 ± 16 µM = TBH, n = 6) in
the freshly prepared PN solution (16 ± 5 µM = TBH)
as well as in newly reconstituted 5-mL vials of MVI (3280 ± 110 µM = TBH). However, the actual peroxide load measured in
TPN solutions (Figs 1, 2) reflected the
dilution of the original constituents.
Fig. 1.
Influence of a lipid emulsion and daylight on peroxide levels in
freshly prepared solutions of PN devoid of multivitamins (PN and
PN + LIPID). The data represent the mean ± SEM, n = 3; the variations are not depicted because of their small size relative to
the symbols. There was a significant difference
(P < .001) between PN and PN + LIPID on
peroxide content, whereas daylight had no effect
(F(1,64) = 0).
[View Larger Version of this Image (26K GIF file)]
Fig. 2.
Influence of a lipid emulsion and daylight on peroxide levels in
freshly prepared solutions of parenteral nutrition containing multivitamins (PN + MVI and PN + LIPID + MVI). The data
represent the mean ± SEM, n = 3; the variations are not
depicted because of their small size relative to the symbols. The
peroxide content rose significantly over time (P < .001), and exposure to daylight had a significant effect on peroxide
generation (P < .001).
[View Larger Version of this Image (25K GIF file)]
Figure 1 presents the variation over time in peroxide contents of
solutions without MVI. It appears that the addition of the lipid
emulsion at a final concentration of 5.5% (v/v) resulted in a
threefold higher peroxide content (P < .001),
which remained constant over time. Overall, exposure to daylight had no
effect (F(1,64) = 0) on the solutions
devoid of MVI. From Figure 2, it appears that immediately on
preparation of the solutions, the addition of multivitamins resulted in
a significantly higher initial peroxide content compared with PN
(16 ± 5 vs 66 ± 5 µM = TBH, n = 6) and
to PN + LIPID (83 ± 3 vs 126 ± 6 µM = TBH, n = 6). In the presence of MVI, the peroxide content rose
significantly over time (P < .001), and the
exposure to daylight had a rapid and dramatic effect on stimulating
peroxide generation (P < .001). From Figures 1 and 2, it appears that the presence of lipids had only an additive
effect to that of MVI; the lipid emulsion did not potentiate the
generation of peroxides induced by MVI.
Three hours after exposure to light, the addition of catalase to the
PN + LIPID + MVI solution produced a 88% drop in peroxides, confirming that H2O2 was the main source of
peroxides. Bisulfite produced a 100% drop in peroxides.
The dose-response relationship in Fig 3 underlines the
direct effect of MVI content on peroxide generation in the presence of
light. It is worth noting that the peroxide content, measured at an MVI
concentration of 1% (v/v), corresponds to what was documented in
Figure 2. From Fig 4, it appears that contrary to MVI,
the amino acid solution had a protective effect, because a lower amino acid concentration resulted in a significant increase in peroxides in
the face of a constant MVI concentration.
Fig. 3.
Dose-response relationship between peroxide content and MVI admixture
in PN in water after 3 h of exposure to daylight.
[View Larger Version of this Image (15K GIF file)]
Fig. 4.
Influence of a 24-h exposure to daylight on peroxide content in
preparations with varying amino acid content and constant MVI
concentration (1%) relative to the final volume. The data represent
the mean ± SEM, n = 3; the variations are not depicted because of their small size relative to the symbols. Despite a constant
MVI content, peroxide generation was inhibited by increasing amino acid
concentrations, suggesting a protective effect.
[View Larger Version of this Image (17K GIF file)]
The protective effect of different commercially available amino acid
solutions is presented in the Table and expressed as a
percentage inhibition of peroxide generation by MVI. The comparison between Blend C and TIV revealed that bisulfite is not accountable for
the protective effect of the amino acid solutions. The addition of 500 mg/L cysteine hydrochloride to Aminosyn and Blend C showed a specific
effect related to the amino acid solution; the interaction was
significant (P < .01). The addition of cysteine
hydrochloride to Aminosyn produced an increase of 5% in the
antiperoxide property (P < .05) of the final
solution; in Blend C, the addition of cysteine hydrochloride diminished
by 6% (P < .01) the protective capacity of the
solution.
|
Table 1.
Percent of Inhibition of Peroxide Generation by MVI
[View Table]
|
The peroxide concentrations measured in actual TPN solutions being
delivered to premature infants were similar to those reproduced on the
bench (Fig 5). The difference between sampling sites
showed that the transit through the extension set was associated with a
higher peroxide concentration (P < .01). The
rate of increase in the level of peroxides was higher in the group
exposed to light, as documented by the statistically significant
interaction (P < .05) between the effects of
light and sampling sites. There was no difference in the infusion rates
(4.9 mL/h ± 0.1 mL/h vs 5.2 mL/h ± .3 mL/h) or the MVI
concentrations (1.9% ± 0.2% vs 1.8% ± .2%) between the two groups
of six patients each (weight: 975 g ± 63 g vs 937 g ± 55 g).
Fig. 5.
Comparison of peroxide concentrations (µM = TBH) measured
in actual fat-free TPN solutions being delivered to premature infants. Values (mean ± SEM, n = 6) represent peroxides sampled in
the bag of TPN or in the extension set close to the infant. Two groups of six infants were studied while on comparable TPN regimens; those
with extension sets protected from light received a significantly lower
infusion of peroxides.
[View Larger Version of this Image (21K GIF file)]
DISCUSSION
The important findings of this study are that the multivitamin
preparation is the major contributor to in vitro
peroxidation and that commercially available amino acid preparations
offer some degree of protection in the final solution. Our measurements were validated previously by recovery of externally added peroxides such as TBH, H2O2, and cumen
peroxide,8 and furthermore, we found in Intralipid-10%
peroxide levels that were in the same range as those reported for the
10% lipid emulsion Liposyn1 despite differing analytical
techniques. This is further supported by the drop in peroxide content
after catalase or bisulfite admixture.
The generation of peroxides in MVI could be related to photooxidation
in the presence of riboflavin and amino acids such as tryptophan,
tyrosine, methionine, cysteine, and phenylalanine.6 However, MVI was found to generate peroxides even in the absence of
amino acid admixture (Figs 3, 4). Therefore, other constituents of MVI,
such as detergents, might account for the spontaneous photooxidation
(Figs 3, 4). Indeed, the multivitamin preparation contains polysorbate
80 and polysorbate 20 at concentrations of 1% (w/v) and .02%,
respectively. Both of these nonionic detergents are highly susceptible
to peroxidation by photooxidation, even at concentrations as low as
.1%.17,20 These detergents are the same as those that were
implicated, at 10-fold higher concentrations, in an unusual fatal
syndrome among premature infants, characterized by unexplained clinical
deterioration.21,22 Additional information is needed to
verify the clinical impact of these detergents in multivitamin
preparations.
The dose-response relationship (Fig 3) underscores the potential risk
of inadvertently infusing higher concentrations of peroxides than those
reported in this study during the weaning of intravenous alimentation.
Indeed, if the volume of administered MVI is kept constant while the
total volume of fluids to be infused is decreased, the patients will
receive concentrations of MVI that can reach >5% during the weaning
process, with dramatic effects on peroxide concentrations.
The magnitude of peroxides infused with the studied solutions
corresponds to H2O2 released during
phagocytosis by 10 000 human neutrophils per mL over 24 h.23,24 In red cells, an organic peroxide stimulates
proteolysis at concentrations lower than those in the studied
solutions, whereas 200 µM H2O2
had no such effect.25 Therefore, infused peroxides are
potentially cytotoxic under conditions of weak peroxidase activity, as
found in the lung and liver of preterm and term neonates.26
Furthermore, these immature infants receive the highest concentrations
of MVI (up to 5% v/v) when compared with adolescents and adults (0.1%
v/v). Although newborn infants are at greater risk of being unable to
counter effectively an oxidative challenge such as that represented by
TPN, the biological significance of the infused peroxides remains to be
proven.
The experimental conditions closely mimic the clinical practice in
neonatal units, where the TPN solution can be exposed to light for
periods as long as 4 h during its transit through the tubing from
the bag to the infant. Protecting the extension set from light produced
a significant (P < .01) drop in the amount of
peroxides infused in these infants. These data suggest that the use of
tubing shielded from light would diminish the oxidant load associated
with TPN. The study was not designed to find the best protection from
light, but rather to emphasize the magnitude of the phenomenon of
photooxidation on MVI under clinical conditions. The group with the
tubing shielded from light had a better photoprotection of the bag,
because the bottom of its opaque cover was completely closed as opposed
to the other group, the bag for which was open toward the bottom,
resulting in a higher peroxide concentration (Fig 5). This point
stresses the importance of the quality of the shielding from light. The
biological significance of protecting the TPN solutions from light has
been documented in animals by others researchers, who showed that light
exposure was associated with an increase in biliary concentrations of
oxidized glutathione and free amino acids.27
The amino acid solutions presented a relative protection against
peroxidation. It appears that the inhibition of peroxide generation
varied from 54% to 72% (Table1). The significant interaction between
cysteine and amino acid blends indicates that statistical comparisons
between the different solutions were not warranted and suggests that
the variation in the protective effect depends above all on differing
amino acid blends. The antiperoxide property of these solutions might
not be desirable if certain amino acids become oxidized in the
process.16 Indeed, data not presented show that the thiol
function of cysteine was lost in the presence of peroxides. This raises
the question as to whether the amino acid blend showing the least
antiperoxide activity (Table 1) is the one that conserves best its
original composition. This point is emphasized further when considering
the fall in peroxide concentrations in PN solutions after 6 h (Fig
4). The balance between generation and consumption of peroxides is
positive during the first 6 h after preparation. After that time,
we presume that the balance changed in favor of the consumption of
peroxides during their transformation into free radicals via the
Fenton-like reaction9 induced by trace elements present in
the PN solutions. This is supported by the absence of a fall in
peroxides in the solution devoid of trace elements (Fig 4). The fact
that added cysteine presented a different redox effect in Aminosyn and
Blend C might not be solely related to the amino acid blend but also to
the level of peroxides, as well as to trace elements and free radicals present in these solutions. In general, we wish to emphasize that an
antioxidant can become prooxidant depending on the concentration of
peroxides, as documented previously with bisulfite.8
In conclusion, a greater effort should be made to decrease the level of
peroxides in TPN solutions. Protection from photooxidation is not
sufficient to prevent peroxidation of TPN solutions (Figs 2, 5). We
caution against choosing an amino acid solution for its antiperoxide
properties. Contrary to what one would expect, increasing the
concentration of MVI will lead to a greater generation of peroxides,
suggesting that the essential antioxidants in MVI do not have
antiperoxide properties. It remains to be verified whether the
detergents represent a source of peroxides that could be eliminated by
separating the multivitamins between the hydrosoluble and liposoluble
fractions, the later being infused with the lipids. The biological
significance of the infused peroxides remains to be proven.
FOOTNOTES
Received for publication Jun 17, 1996; accepted Oct 3, 1996.
Address correspondence to: Philippe Chessex, MD, Research
Center of Hospital Sainte-Justine, 3175 Chemin Côte
Sainte-Catherine, Montreal, Quebec, Canada H3T 1C5.
ACKNOWLEDGMENTS
This work was supported by a grant from The Hospital for Sick
Children Foundation, Toronto, Ontario, Canada.
We wish to thank Jocelyne Vallée, RN, for her help in collecting
the samples at the bedside. Clintec Canada and Abbott Laboratories provided the amino acid solutions used in this study.
ABBREVIATIONS
TPN, total parenteral nutrition.
TBH, tert-butyl
hydroperoxide.
PN, fat-free and vitamin-free parenteral nutrition.
MVI, multivitamin preparation.
REFERENCES
-
Helbock HJ,
Motchnik PA,
Ames BN
Toxic hydroperoxides in
intravenous lipid emulsions used in preterm infants.
Pediatrics.
1993;
91:83-88 [Medline][Abstract/Free Full Text]
-
Pitkänen O,
Hallman M,
Anderson S
Generation of free radicals in
lipid emulsion used in parenteral nutrition.
Pediatr Res.
1991;
29:56-59 [Medline]
-
Gebicki S,
Gebicki JM
Formation of peroxides in amino acids and
proteins exposed to oxygen free radicals.
Biochem J.
1993;
289:743-749 [Medline]
-
Wang RJ,
Nixon BT
Identification of hydrogen peroxide as a
photoproduct toxic to human cells in tissue-culture medium irradiated
with "daylight."
In Vitro.
1978;
14:715-722 [Medline][Medline]
-
Link G,
Pinson A,
Kahane I,
Hershko C
Iron loading modifies the fatty
acid composition of cultured rat myocardial cells and liposomal
vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid
peroxidation.
J Lab Clin Med
1989;
114:243-249 [Medline][Medline]
-
Brawley V,
Bhatia J,
Karp WB
Hydrogen peroxide generation in a model
pediatric parenteral amino acid solution.
Clin Sci.
1993;
85:709-712[Medline]
-
Machlin LJ,
Bendich A
Free radical tissue damage: protective role of
antioxidant nutrients.
FASEB J.
1987;
1:441-445 [Medline][Abstract]
-
Lavoie JC,
Lachance C,
Chessex P
Antiperoxide activity of sodium
metabisulfite: a double-edged sword.
Biochem Pharmacol.
1994;
47:871-876 [Medline][CrossRef][Medline]
-
Lunec J
Free radicals: their involvement in disease process.
Ann
Clin Biochem.
1990;
27:172-182
-
Kennedy K
Dietary antioxidants in the prevention of oxygen-induced
injury.
Semin Perinatol.
1989;
13:97-103 [Medline][Medline]
-
Pitkänen OM
Peroxidation of lipid emulsions; a hazard for the
premature infant receiving parenteral nutrition?
Free Radic Biol
Med
1993;
13:239-245
-
Bhatia J,
Mims LC,
Roesel RA
The effect of phototherapy on amino acid
solutions containing multivitamins.
J Pediatr.
1980;
96:284-286 [Medline][CrossRef][Medline]
-
Dhanakoff SN,
Draper HH
Response of urinary malondialdehyde to factors
that stimulate lipid peroxidation in vivo.
Lipids.
1987;
22:643-646[Medline]
-
Lavoie JC,
Chessex P
Gender-related response to a tert-butyl
hydroperoxide-induced oxidation in human neonatal tissue.
Free
Radic Biol Med
1994;
16:307-313 [Medline][CrossRef][Medline]
-
Neuzil J,
Darlow BA,
Inder TE,
Sluis KB,
Winterbourn CC,
Stocker R
Oxidation of parenteral lipid emulsion by ambient and phototherapy
lights: potential toxicity of routine parenteral feeding.
J
Pediatr.
1995;
126:785-790 [Medline][CrossRef][Medline]
-
Bhatia J,
Stegink LD,
Ziegler EE
Riboflavin enhances photo-oxidation
of amino acids under simulated clinical conditions.
J Parenter
Enter Nutr.
1983;
7:277-279[Abstract]
-
Ding S
Quantitation of hydroperoxides in the aqueous solutions of
non-ionic surfactants using polysorbate 80 as the model surfactant.
J Pharm Biochem Anal.
1993;
2:95-101
-
White W,
Stabler SP,
Alle RH,
Moreland S,
Rosenberg AA
Plasma cysteine
concentrations in infants with respiratory distress.
J
Pediatr.
1994;
125:769-777[CrossRef][Medline]
-
Jiang ZY,
Woollard ACS,
Wolff SP
Lipid hydroperoxide measurement by
oxidation of Fe2+ in the presence of xylenol orange. Comparison with
the TBA assay and an iodometric method.
Lipids.
1991;
26:853-856 [Medline][Medline]
-
Jaeger J,
Sorensen K,
Wolff SP
Peroxide accumulation in detergents.
J Biochem Biophys Methods.
1994;
29:77-81 [Medline][CrossRef][Medline]
-
Bove KE,
Kosmetatos N,
Wedig K,
Frank DJ,
Whitlach S,
Saldivar V,
Haas J,
Bodenstein C,
Balistreri WF
Vasculopathic hepatotoxicity associated
with E-Ferol syndrome in low-birth-weight infants.
JAMA.
1985;
254:2422-2430 [Medline][Abstract]
-
Lorch V,
Murphy D,
Hoersten LR,
Harris E,
Fitzgerald J,
Sinha S
Unusual syndrome among premature infants: association with a new
intravenous Vitamin E product.
Pediatrics.
1985;
75:598-602 [Medline][Abstract/Free Full Text]
-
Roos D,
Weening RS,
Votema AA
Protection of human neutrophils against
oxidative damage.
Agents Actions.
1980;
10:528-535 [Medline][CrossRef][Medline]
-
Fuortes M, Nathan C. Role of CD11/CD18 integrins and cAMP in the
TNF-induced respiratory burst of human neutrophils. In: Jesaitis AJ,
Dratz EA, eds. The Molecular Basis of Oxidative Damage by
Leukocytes. Ann Arbor: CRC Press; 1992:81-90
-
Runge-Morris M,
Frank P,
Novak RF
Differential effects of organic
hydroperoxides and hydrogen peroxide on proteolysis in human
erythrocytes.
Chem Res Toxicol.
1989;
2:76-83 [Medline][CrossRef][Medline]
-
Rickett M,
Kelly FJ
Developmental expression of antioxidant enzymes in
guinea pig lung and liver.
Development.
1990;
108:331-336[Abstract]
-
Shattuck KE,
Bhatia J,
Grinnell C,
Rassin DK
The effects of light
exposure on the in vitro hepatic response to an amino acid-vitamin
solution.
J Parenter Enter Nutr.
1995;
19:398-402
[Abstract]